These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7747277)

  • 41. Metabolism of antipyrine and m-xylene in rats after prolonged pretreatment with xylene alone or xylene with ethanol, phenobarbital or 3-methylcholanthrene.
    Elovaara E; Engström K; Häyri L; Hase T; Aitio A
    Xenobiotica; 1989 Sep; 19(9):945-60. PubMed ID: 2815836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of erythromycin on hepatic drug-metabolizing enzymes in humans.
    Larrey D; Funck-Brentano C; Breil P; Vitaux J; Theodore C; Babany G; Pessayre D
    Biochem Pharmacol; 1983 Mar; 32(6):1063-8. PubMed ID: 6838653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clonidine effects on disposition of xenobiotics in rats: inhibited elimination of flow-limited but not extraction-limited agents.
    Ben-Zvi Z; Hurwitz A
    Br J Pharmacol; 1988 May; 94(1):97-102. PubMed ID: 3401645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolism of simultaneously administered antipyrine and theophylline in male BN/BiRij rats before and after induction with 3-methylcholanthrene.
    Groen K; Breimer DD; van Bezooijen CF
    Drug Metab Dispos; 1992; 20(4):502-6. PubMed ID: 1356725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of H2-receptor antagonists on antipyrine and pentobarbital metabolism in male and female rats.
    Tanaka E; Nakamura K; Misawa S; Kuroiwa Y
    Jpn J Pharmacol; 1988 Jan; 46(1):79-82. PubMed ID: 2896806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug metabolizing capacity in vitro and in vivo--I. Correlations between hepatic microsomal monooxygenase markers in beta-naphthoflavone-induced rats.
    Matthew DE; Houston JB
    Biochem Pharmacol; 1990 Aug; 40(4):743-9. PubMed ID: 2386543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of sizofilan, an immunomodulator, on hepatic microsomal mixed-function oxidase activities in rats.
    Yomogida S; Koiwai K; Shiba Y; Ishikawa M; Takayanagi Y; Sasaki K
    Jpn J Pharmacol; 1989 Aug; 50(4):499-502. PubMed ID: 2528647
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of the oral contraceptive, menstranol, on drug-metabolizing enzymes of female rats in thiamin-supplemented and deficiency states.
    Wade AE; Evans JL; Seitz A
    Pharmacology; 1976; 14(2):104-14. PubMed ID: 822434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of diltiazem on hepatic drug metabolizing enzymes in man using antipyrine, trimethadione and debrisoquine as model substrates.
    Sakai H; Kobayashi S; Hamada K; Iida S; Akita H; Tanaka E; Uchida E; Yasuhara H
    Br J Clin Pharmacol; 1991 Mar; 31(3):353-5. PubMed ID: 2054276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of short-term water deprivation on antipyrine disposition.
    Prasad P; Jung D; Niazi S
    J Pharm Sci; 1985 Mar; 74(3):338-9. PubMed ID: 4009446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aminopyrine metabolism by multiple forms of cytochrome P-450 from rat liver microsomes: simultaneous quantitation of four aminopyrine metabolites by high-performance liquid chromatography.
    Imaoka S; Inoue K; Funae Y
    Arch Biochem Biophys; 1988 Aug; 265(1):159-70. PubMed ID: 3415241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of chronic parenteral carbohydrate administration on hepatic drug metabolism in the rat.
    Hartshorn RD; Demers LM; Sultatos LG; Vesell ES; Lang CM; Hughes HC
    Pharmacology; 1979; 18(2):103-11. PubMed ID: 218235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of curcumin, capsaicin, and piperine on the rat liver drug-metabolizing enzyme system in vivo and in vitro.
    Suresh D; Srinivasan K
    Can J Physiol Pharmacol; 2006 Dec; 84(12):1259-65. PubMed ID: 17487234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Monooxigenase activity in liver diseases (study based on data of antipyrine metabolism)].
    Loginov AS; Bendikov EA; Kel'nia ZhA; Petrakov AV
    Ter Arkh; 1987; 59(2):84-9. PubMed ID: 3576485
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction between antipyrine and aminopyrine.
    Vesell ES; Passananti GT; Hepner GW
    Clin Pharmacol Ther; 1976 Dec; 20(6):661-9. PubMed ID: 991537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lack of in vitro and in vitro effects of fenbendazole on phase I and phase II biotransformation enzymes in rats, mice and chickens.
    Dalvi RR; Gawai KR; Dalvi PS
    Vet Hum Toxicol; 1991 Dec; 33(6):548-51. PubMed ID: 1808827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatic drug clearance in patients with mild cystic fibrosis.
    Kearns GL; Crom WR; Karlson KH; Mallory GB; Evans WE
    Clin Pharmacol Ther; 1996 May; 59(5):529-40. PubMed ID: 8646824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes.
    Ahn D; Putt D; Kresty L; Stoner GD; Fromm D; Hollenberg PF
    Carcinogenesis; 1996 Apr; 17(4):821-8. PubMed ID: 8625497
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of antipyrine and rifampin on the metabolism of diazepam.
    Ohnhaus EE; Brockmeyer N; Dylewicz P; Habicht H
    Clin Pharmacol Ther; 1987 Aug; 42(2):148-56. PubMed ID: 3608348
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Down-regulation of cytochrome P450 proteins and its activities by Shiga-like toxin II from Escherichia coli O157:H7.
    Kitaichi K; Nakayama H; Ueyama J; Nadai M; Baba K; Takagi K; Takagi K; Ohta M; Hasegawa T
    Biochem Pharmacol; 2004 Apr; 67(8):1427-35. PubMed ID: 15041460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.